Fernanda das Chagas A Silva

Learn More
The present study compared morphological, histochemical and histomorphometric characteristics of the sublethal effects of XenTari® and deltamethrin in blastocyst-endometrium interactions in female rats. Pregnant rats received 185, 1850 and 3700mg of XenTari® or 1.0, 2.0 and 4.0mg of deltamethrin (all doses per kg of body weight) and were sacrificed on the(More)
BACKGROUND Pioglitazone is a peroxisome proliferator-activated receptor gamma (PPARγ) activator used in the treatment of type 2 diabetes (DM2) patients and it has been suggested that can induce bone loss. Tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6) mRNA expression in blood leukocytes and the relationship with polymorphisms and bone markers in(More)
  • 1